Drug Markets/Exenatide

Exenatide

3 NDCs across 2 manufacturers|1 Generic,2 Brand

Exenatide is used to treat type 2 diabetes mellitus, per the National Library of Medicine's MED-RT classification.

▸ More about this market

In 2024, Medicare Part D spent $16 million on Exenatide across 12,000 claims for 3,043 beneficiaries.

Exenatide is available as 3 NDCs from 2 manufacturers (1 generic, 2 brand), with NADAC prices from $300.17 to $681.26 per ML — the most expensive product costs about 2.3× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

3

1G / 2B

Manufacturers

2

competing in market

Price Spread

$300.17 – $681.26

per ML

7d Activity

3 flat

avg +0.0% WoW · of 3 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Drug Portfolio

3 NDCs total, 3 shown

Frequently Asked Questions

What is Exenatide used to treat?

Exenatide is used to treat type 2 diabetes mellitus, per the National Library of Medicine's MED-RT classification.

How much does Medicare spend on Exenatide?

In 2024, Medicare Part D spent $16 million on Exenatide across 12,000 claims for 3,043 beneficiaries.

How many Exenatide products are on the market?

The Exenatide drug market contains 3 NDCs from 2 manufacturers — 1 generic and 2 brand products.

What is the price range for Exenatide?

NADAC reference prices for Exenatide range from $300.1675 to $681.2626 per ML — the most expensive product costs about 2.3× the cheapest.

Is generic Exenatide cheaper than brand?

The average generic NADAC for Exenatide is $300.1675 per ML, versus $510.6820 for brand-labeled products — generic is about 41% cheaper on average.

Which manufacturers make Exenatide?

2 manufacturers list Exenatide in NADAC. Ranked by number of NDCs, the largest are AstraZeneca Pharmaceuticals LP (2), Amneal Pharmaceuticals LLC (1).